Rockville, MD, USA, Dec. 06, 2017 -- The Regulatory Affairs Professionals Society (RAPS) has published the updated, eighth edition of Fundamentals of EU Regulatory Affairs, the most extensive reference available on regulatory affairs for pharmaceuticals, medical devices, biologics and other healthcare products intended for the European market. The book is an essential reference for anyone who needs to know and understand rules and regulations from the European Medicines Agency, the European Commission or individual European national agencies. This new edition has been fully updated and is current through September 2017.
|
||||||
“Regulations governing healthcare products for the European market have been subject to major changes recently, so the new, updated edition of Fundamentals of EU Regulatory Affairs comes at an opportune time,” said RAPS Executive Director Paul Brooks. “Perhaps the biggest changes have been in the medical device area as new EU Medical Device Regulation and EU In Vitro Diagnostic Regulation were adopted this year and will go into full effect in 2020 and 2022, respectively. There are also changes ahead for medicinal product regulation. The pending European Clinical Trials Regulation could change how trials are conducted in the EU.”
View the Table of Contents and a sample chapter, Regulatory Information Resources.
RAPS also has published two sector-specific EU fundamentals books, Fundamentals of EU Medical Device Regulations and Fundamentals of EU Pharmaceutical & Biologics Regulations, which present the same content published in the parent, eighth edition, but limited to only that which is relevant to one sector or the other. This allows those who work exclusively in a particular industry to get all the information that is pertinent to them without additional content that may not be.
The list price for the full eighth edition is $395 (US)—about €335 at the current exchange rate—while RAPS members get $100 off that price. Each of the sector-specific books is available for $200 list (around €170, currently), and $150 for members. The full eighth edition is available in both print and e-book versions. The sector-specific collections are available as e-books only.
Fundamentals of EU Regulatory Affairs is useful to regulatory and legal professionals, professors, students, career-changers and government officials as a trusted reference, academic textbook and Regulatory Affairs Certification (RAC) study tool.
For more information or to order any of the fundamentals books, visit RAPS.org/fundamentals.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f408443a-047a-4949-a81d-f84e22c0260a
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/01e0b4b5-7520-4d90-9cd4-0247768b985b
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



